Pure Global AI
NCT06383130Not yet recruiting

London Asthma Diagnostics Study

A Pragmatic Diagnostic Accuracy Study of a Triple Diagnostic Approach and Exploratory Biomarkers in Adult Asthma Diagnosis
Imperial College LondonClinicalTrials.govdiagnostic test
Study focus
Disease/Condition
Asthma
Drug/Device/Intervention
Oscillometry with reversibility testing
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Imperial College London
Location
London,London,Nottingham, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jul 01, 2026
Enrollment
225 participants
Primary outcome

To evaluate the diagnostic accuracy (sensitivity, specificity) of a combination of oscillometry ± reversibility, spirometry ± reversibility and FeNO

Summary

The goal of this trial is to learn if the addition of oscillometry with reversibility testing
 increases diagnostic accuracy in adult asthma diagnosis, when added to current standard of
 care tests: spirometry with reversibility testing and Fractional Exhaled Nitric Oxide (FeNO).
 The main question it aims to answer is:
 
 - Does oscillometry with reversibility testing increase diagnostic accuracy in detection of
 asthma in adults when added to spirometry with reversibility and FeNO?
 
 Researchers will evaluate the diagnostic accuracy of this approach with the reference
 standard, which is a clinically adjudicated diagnosis of asthma by two respiratory clinicians
 based on history and investigation results.
 
 Participants will
 
 - Undergo oscillometry testing alongside their routine asthma investigations within their
 scheduled clinic visit
 
 - Optionally participate in our sub-studies on new breath and nasal swab tests for asthma
 
 - Optionally participate in our qualitative substudy on patients views and attitudes to
 asthma testing and oscillometry

ICD-10 classifications
AsthmaAsthma, unspecifiedNonallergic asthmaMixed asthmaPredominantly allergic asthma
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06383130
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06383130 through Pure Global AI's free database. This phase not specified trial is sponsored by Imperial College London and is currently Not yet recruiting. The study focuses on Asthma. Target enrollment is 225 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.